Home / Inspections / 1051026

FDA Inspection 1051026 — Clinical Laboratories of Hawaii, LLP

Clinical Laboratories of Hawaii, LLP — FEI 2972911

The FDA completed an inspection of Clinical Laboratories of Hawaii, LLP on April 18, 2018 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 18, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Honolulu, HI (United States)

Additional Details

Clinical BA/BE

Facility

Other inspections at this facility

  • 1280587 (NAI Thu Aug 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1279652 (NAI Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1208208 (VAI Thu Jun 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1055322 (NAI Thu May 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1053641 (VAI Wed May 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources